Anonymous
Guest
Anonymous
Guest
Many thanks goes out to Abbvie for negotiating an exclusive contract with ESI for their new HCV med this week, which has turned the biotech sector on its head.....power shifts to the payers and we all know that the Feds will want a bigger discount going forward, reducing our profits and revenue, leading to layoffs/downsizing.......happy holidays